Differential Expression of Inflammation-Related Genes in Down Syndrome Patients with or without Periodontal Disease.

Aim: Aware that Down Syndrome patients present among their clinical characteristics impaired immunity, the aim of this study is to identify the statistically significant differences in inflammation-related gene expression by comparing Down Syndrome patients with Periodontal Disease (DS+PD+) with Down Syndrome patients without Periodontal Disease (DS+PD-), and their relationship with periodontitis as a chronic oral inflammatory clinical feature.

Materials And Methods: Case study and controls on eleven Down Syndrome patients (DS+PD+ vs. DS+PD-). RNA was extracted from peripheral blood using a Qiagen PAXgene Blood miRNA Kit when performing an oral examination. A search for candidate genes (92 selected) was undertaken on the total genes obtained using a Scientific GeneChip® Scanner 3000 (Thermo Fisher Scientific) and Clariom S solutions for human, mouse, and rat chips, with more than 20,000 genes annotated for measuring expression levels.

Results: Of the 92 inflammation-related genes taken initially, four genes showed a differential expression across both groups with a value of <0.05 from the data obtained using RNA processing of the patient sample. Said genes were TNFSF13B ( = 0.0448), ITGB2 ( = 0.0033), ANXA3 ( = 0.0479), and ANXA5 ( = 0.016).

Conclusions: There are differences in inflammation-related gene expression in Down Syndrome patients when comparing patients who present a state of chronic oral inflammation with patients with negative rates of periodontal disease.